no statement of use filed
on 13 Jun 2022
Last Applicant/ Owned by
430 E. 29th Street, 14th Floor
New York
NY
10016
Serial Number
90271697 filed on 22nd Oct 2020
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing
No 90271697
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Jun 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
13th Jun 2022 | ABANDONMENT - NO USE STATEMENT FILED |
09th Nov 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
14th Sep 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
14th Sep 2021 | PUBLISHED FOR OPPOSITION |
26th Aug 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
06th Aug 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
06th Aug 2021 | EXAMINER'S AMENDMENT ENTERED |
06th Aug 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
06th Aug 2021 | EXAMINERS AMENDMENT E-MAILED |